The White House decreed on Monday, January 18, that the entry bans on most of the European Union, the United Kingdom, and Brazil would end as early as January 26, just six days after Mr. Biden takes office, citing the decision last week by the administration to require international travelers to present either the results of a negative recent coronavirus test or evidence that they had already recovered from the disease. President-elect Biden rejected the move, which means the curbs on incoming travel from these regions, which have been in place since March 2020, will remain in place after the inauguration. "On the advice of our medical team, the administration does not intend to lift these restrictions on 1/26," tweeted Jen Psaki, spokeswoman for the Biden administration, immediately after President Trump's decree was issued. "In fact, we plan to strengthen public health measures around international travel in order to further mitigate the spread of COVID-19."
The recent decision by the Centers for Disease Control and Prevention to require a negative COVID-19 test for travelers arriving from other countries was reported not to be directly linked to the travel ban, but it was seen as a way to impose safety restrictions that would allow for a resumption of travel. Martin Centron, the CDC's director of the division of global migration and quarantine, said last week that "[p]rotecting the global public's health while minimizing the interference to travel and trade is essentially our goal." The use of testing – both before travel and upon arrival – to facilitate travel has been adopted by jurisdictions across a number of regions in the new year.
The debate by the two administrations arises as the United States has reported more than 24 million cases of coronavirus, and the deaths of nearly 400,000 Americans infected with the disease. It also comes amid a struggle across nations with a new, more contagious variant of the virus.
Visit us at mayerbrown.com
Mayer Brown is a global legal services provider comprising legal practices that are separate entities (the "Mayer Brown Practices"). The Mayer Brown Practices are: Mayer Brown LLP and Mayer Brown Europe - Brussels LLP, both limited liability partnerships established in Illinois USA; Mayer Brown International LLP, a limited liability partnership incorporated in England and Wales (authorized and regulated by the Solicitors Regulation Authority and registered in England and Wales number OC 303359); Mayer Brown, a SELAS established in France; Mayer Brown JSM, a Hong Kong partnership and its associated entities in Asia; and Tauil & Chequer Advogados, a Brazilian law partnership with which Mayer Brown is associated. "Mayer Brown" and the Mayer Brown logo are the trademarks of the Mayer Brown Practices in their respective jurisdictions.
© Copyright 2020. The Mayer Brown Practices. All rights reserved.
This Mayer Brown article provides information and comments on legal issues and developments of interest. The foregoing is not a comprehensive treatment of the subject matter covered and is not intended to provide legal advice. Readers should seek specific legal advice before taking any action with respect to the matters discussed herein.
